In patients with type 2 diabetes, we found generally a significant genotype effect; such that individuals with B1B1 genotype showed a significant decrease in apoB, apoB: apoA-1, insulin, and HOMA-IR and also an increase in QUICKI compared with B2B2 homozygotes. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.